Csl Ltd
About
Csl Ltd (AU:CSL) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 9 2026
CSL announces expansion of Illinois plasma therapy manufacturing facility
Mar 6 2026
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
Feb 11 2026
CSL Half Year Results Investor Presentation
Feb 11 2026
CSL Statutory Accounts for the Half Year Ended 31 December
Feb 11 2026
CSL Half Year Results Announcement
Financials
Revenue
A$15.41 B
Market Cap
A$69 B
P/E Ratio
15.78
EPS
9.01
Dividend Yield
2.07%